Tuesday, January 07, 2020 9:30:46 AM
I think the last of the $MILV 3s may be gone any minute.
One of many reasons is the awesome DD like one of the major shareholders, who holds 131 issued patents in the biotech field of Lioposomes
Was part of "The Liposome Company" that ended up being acquired for $575 Million by Elan in 2000.
https://www.thepharmaletter.com/article/elan-to-acquire-the-liposome-company
What is unique about this is that the patents utilized for this company were majority of Michael W. Fountains work. This company was acquired back in 2000.
These are much older patents that do not entertain the 15-100 nm "small" or "micro" liposome technology that can pass through the BBB - Blood Brain Barrier.
Subsequently, Elan Corp gets acquired by Perrigo in 2013 for an estimate of $8.6 Billion. Obviously, Elan isn't just made up of Liposome technology.
https://investor.perrigo.com/2013-12-18-Perrigo-Company-plc-Completes-Acquisition-of-Elan-Corporation-plc
So, what I am trying to tell people here is that...... THIS IS A GOLD MINE.
We have new patents that allow researchers to take their uniquely developed compounds and insert them into Michael W. Fountains liposome technology, and carry them through the blood brain barrier and onto their target destination (explanation gets more nitty gritty).
Just an $MILV reminder folks. The loading zone in the .003x zone may close at any time.
Way undervalued, with solid bid support, as the weak hands get cleared out.
290 Mil share float. No debt. No new shares and!!!!
One of many reasons is the awesome DD like one of the major shareholders, who holds 131 issued patents in the biotech field of Lioposomes
Was part of "The Liposome Company" that ended up being acquired for $575 Million by Elan in 2000.
https://www.thepharmaletter.com/article/elan-to-acquire-the-liposome-company
What is unique about this is that the patents utilized for this company were majority of Michael W. Fountains work. This company was acquired back in 2000.
These are much older patents that do not entertain the 15-100 nm "small" or "micro" liposome technology that can pass through the BBB - Blood Brain Barrier.
Subsequently, Elan Corp gets acquired by Perrigo in 2013 for an estimate of $8.6 Billion. Obviously, Elan isn't just made up of Liposome technology.
https://investor.perrigo.com/2013-12-18-Perrigo-Company-plc-Completes-Acquisition-of-Elan-Corporation-plc
So, what I am trying to tell people here is that...... THIS IS A GOLD MINE.
We have new patents that allow researchers to take their uniquely developed compounds and insert them into Michael W. Fountains liposome technology, and carry them through the blood brain barrier and onto their target destination (explanation gets more nitty gritty).
Just an $MILV reminder folks. The loading zone in the .003x zone may close at any time.
Way undervalued, with solid bid support, as the weak hands get cleared out.
290 Mil share float. No debt. No new shares and!!!!
All of my posts are strictly opinions and should not be considered to be facts, or investment advise. They are for entertainment purposes only.
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
